{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:23:13Z","timestamp":1793380993619,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jjcc.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T20:46:58Z","timestamp":1668199618000},"page":"364-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"81","author":[{"given":"Yasushi","family":"Ueki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2022.11.005_bb0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0010","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0020","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0025","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 Consensus Document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0030","first-page":"655","article-title":"The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome","volume":"24","author":"Muschart","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0035","first-page":"31","article-title":"Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation","volume":"63","author":"Blankenship","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0040","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1161\/hc2301.092121","article-title":"Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation","volume":"103","author":"Ricciardi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0045","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.CIR.0000156328.28485.AD","article-title":"Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging","volume":"111","author":"Selvanayagam","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCINTERVENTIONS.110.959080","article-title":"Periprocedural myocardial infarction: prevalence, prognosis, and prevention","volume":"3","author":"Lansky","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurheartj\/ehq393","article-title":"Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection","volume":"32","author":"Babu","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0060","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/eht048","article-title":"Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention","volume":"34","author":"Park","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0065","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","article-title":"Periprocedural myocardial infarction and injury in elective coronary stenting","volume":"39","author":"Zeitouni","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jacc.2021.11.047","article-title":"Frequency and outcomes of periprocedural MI in patients with chronic coronary syndromes undergoing PCI","volume":"79","author":"Ueki","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0075","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcin.2015.06.001","article-title":"Incidence and potential mechanism(s) of post-procedural rise of cardiac biomarker in patients with coronary artery narrowing after implantation of an everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent","volume":"8","author":"Ishibashi","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2012.10.013","volume":"6","author":"Muramatsu","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0085","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jacc.2013.07.041","article-title":"Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II Registry (COronary BIfurcation Stenting)","volume":"62","author":"Hahn","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJMra0912134","article-title":"Myocardial infarction due to percutaneous coronary intervention","volume":"364","author":"Prasad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0095","first-page":"534","article-title":"Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: analysis based on the SCAI definition","volume":"89","author":"Zhang","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0735-1097(99)00298-3","article-title":"Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course","volume":"34","author":"Kini","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurheartj\/ehaa885","article-title":"Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data","volume":"42","author":"Silvain","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006752","article-title":"Prognostic impact of periprocedural myocardial infarction in patients undergoing elective percutaneous coronary interventions","volume":"11","author":"Koskinas","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0115","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.jacc.2016.08.059","article-title":"High-sensitivity troponin T and mortality after elective percutaneous coronary intervention","volume":"68","author":"Ndrepepa","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.amjcard.2009.06.032","article-title":"Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes","volume":"104","author":"Feldman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0125","first-page":"410","article-title":"Periprocedural myocardial injury and long-term clinical outcome in patients undergoing percutaneous coronary interventions of coronary chronic total occlusion","volume":"28","author":"Di Serafino","year":"2016","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0135","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jcin.2018.12.005","article-title":"Validation of high-risk features for stent-related ischemic events as endorsed by the 2017 DAPT guidelines","volume":"12","author":"Ueki","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0140","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1253\/circj.CJ-14-1375","article-title":"Association of intravascular ultrasound- and optical coherence tomography-assessed coronary plaque morphology with periprocedural myocardial injury in patients with stable angina pectoris","volume":"79","author":"Kimura","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0145","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcin.2015.01.032","article-title":"Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow)","volume":"8","author":"Stone","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0150","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/eurheartj\/ehab271","volume":"42","author":"Bulluck","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0155","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.110.002451","article-title":"Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies","volume":"123","author":"Patti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0165","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.4244\/EIJ-D-22-00269","article-title":"Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial","volume":"18","author":"Ishihara","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0170","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijcard.2015.11.086","article-title":"Impact of intracoronary adenosine administration during primary PCI: a meta-analysis","volume":"203","author":"Polimeni","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joic.12133","article-title":"Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis","volume":"27","author":"Zhao","year":"2014","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1253\/circj.CJ-08-1059","article-title":"Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis","volume":"73","author":"Iwakura","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0185","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jcin.2018.03.021","article-title":"A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by intravascular ultrasound","volume":"11","author":"Hibi","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0190","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0200","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1373\/clinchem.2013.217943","article-title":"Revision of the troponin T release mechanism from damaged human myocardium","volume":"60","author":"Starnberg","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0205","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0210","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehi760","article-title":"Baseline troponin level: key to understanding the importance of post-PCI troponin elevations","volume":"27","author":"Miller","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCINTERVENTIONS.108.765610","article-title":"Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients","volume":"1","author":"Prasad","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0220","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0225","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2010.07.058","article-title":"With the \"universal definition,\" measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention","volume":"57","author":"Lim","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0230","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0235","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Joint ESC\/ACCF\/AHA\/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0240","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0245","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archinternmed.2011.2275","article-title":"Troponin criteria for myocardial infarction after percutaneous coronary intervention","volume":"172","author":"Novack","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0250","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0255","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.120.047987","article-title":"Myocardial infarction in the ISCHEMIA Trial: impact of different definitions on incidence, prognosis, and treatment comparisons","volume":"143","author":"Chaitman","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0260","first-page":"849","article-title":"Type 4a myocardial infarction: incidence, risk factors, and long-term outcomes","volume":"89","author":"Yang","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.carrev.2017.01.008","article-title":"Troponin I elevation and all-cause mortality after elective percutaneous coronary interventions","volume":"18","author":"Ferreira","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0270","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2459\/JCM.0000000000000660","article-title":"Prognostic value of the high-sensitivity troponin T assay after percutaneous intervention of chronic total occlusions","volume":"19","author":"Cottens","year":"2018","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0275","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jcin.2018.02.006","article-title":"Prognostic and practical validation of current definitions of myocardial infarction associated with percutaneous coronary intervention","volume":"11","author":"Tricoci","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0280","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jcin.2019.07.014","article-title":"Impact of periprocedural myocardial biomarker elevation on mortality following elective percutaneous coronary intervention","volume":"12","author":"Garcia-Garcia","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0285","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jcin.2021.05.006","article-title":"Implications of periprocedural myocardial biomarker elevations and commonly used MI definitions after left main PCI","volume":"14","author":"Wang","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0290","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jcin.2019.06.053","article-title":"A contemporary definition of periprocedural myocardial injury after percutaneous coronary intervention of chronic total occlusions","volume":"12","author":"Goliasch","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0295","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2009.03.063","volume":"54","author":"Prasad","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0300","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/CIRCULATIONAHA.111.061663","volume":"125","author":"Damman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0305","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ahj.2013.09.008","article-title":"Prognostic implications of procedural vs spontaneous myocardial infarction: results from the evaluation of drug eluting stents and ischemic events (EVENT) registry","volume":"166","author":"Bangalore","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0310","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jacc.2012.09.005","article-title":"Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction","volume":"60","author":"Leonardi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0315","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2021.03.018","article-title":"Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention","volume":"333","author":"Liu","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2022.11.005_bb0320","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508722002763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508722002763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:07:40Z","timestamp":1760274460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508722002763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0914508722002763"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2022.11.005","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}